Skip to main content
SpringerLink
Log in

Ependymomas: MIB-1 proliferation index and survival

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The biologic behavior of ependymomas is highly variable, and its correlation with histologic features is at best imprecise. This retrospective study attempted to correlate the malignant histologic characteristics of ependymomas with MIB-1 proliferation index and survival. Biopsy and resection specimens taken from 34 patients who received treatment 1972 to 1996 were histologically examined. The patients' ages range was 1 to 59 years. The histologic specimens were assessed for anaplastic features (necrosis, mitosis, vascular proliferation, cellular pleomorphism, and overlapping of nuclei) and an MIB-1 (Ki-67 antigen) proliferation index was also determined. The overall median MIB-1 proliferation index was 7.8% (range 0.1 – 62.5%). An MIB-1 of 20% was significant for a decrease in survival (RR=5.7) (p=0.0013). The median MIB-1 for patients < 20 years old was 20.6% with range (0.1, 43%), while that for patients > 20 years was 5.1% (range 0.2, 9.4%) (KW p=0.055). Three of 5 histological features evaluated were significantly associated with outcome: > 5 mitotic figures per high-power field, necrosis, and vascular proliferation, but not nuclear overlap or pleomorphism. All pathologic factors except pleomorphism were significantly related to the MIB-1 proliferation index. In brief, our data support the association of poor prognoses in ependymomas with young age, the presence of three to four anaplastic histologic features, and an MIB-1 proliferation index > 20%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Áfra D, Müller W, Slowik F, Wilcke O, Budka H, Túróczy L: Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 69: 243-251, 1983

    Google Scholar 

  2. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Perez-Castillo AM, Genitori L, Lena G, Choux M, Pellissier JF: Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol (Berl) 82: 208-216, 1991

    Google Scholar 

  3. Healey EA, Barnes PD, Kupsky WJ, Scott RM, Sallan SE, Black PM, Tarbell NJ: The prognostic significance of post-operative residual tumor in ependymoma. Neurosurgery 28: 666-672, 1991

    PubMed  Google Scholar 

  4. Liu H, Boggs K, Kidd J: Ependymomas of childhood. I. Histological survey and clinicopathological correlation. Child's Brain 2: 92-110, 1976

    PubMed  Google Scholar 

  5. Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB: Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408-417, 1990

    PubMed  Google Scholar 

  6. Kleihues P, Burger PC, Schcithauer BW: Histologic typing of tumors of the central nervous system. Springer-Verlag, Berlin, 1993

    Google Scholar 

  7. Rorke LB: Relationship of morphology of ependymomas in children to prognosis. Prog Exp Tumor Res 30: 170-174.

  8. Rorke LB, Gilles FH, David RL, Becker LE: Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56: 1869-1886, 1985

    PubMed  Google Scholar 

  9. Zülch K: Brain tumors: Their biology and pathology: Berlin, Springer-Verlag, 1986

    Google Scholar 

  10. Barone BM, Elvidge AR: Ependymomas: a clinical study. J Neurosurg 33: 428-438, 1970

    PubMed  Google Scholar 

  11. Ilgren EB, Stiller CA, Hughes JT, Silberman D, Steckel N, Kaye A: Ependymomas: a clinical and pathologic study. Part II. Survival features. Clin Neuropathol 3: 122-127, 1984

    PubMed  Google Scholar 

  12. Rawlings CE, Giangaspero F, Burger PC, Bullard DE: Ependymomas: a clinicopathologic study. Surg Neurol 29: 271-281, 1988

    PubMed  Google Scholar 

  13. Reyes-Mugica M, Chou PM, Myint MM, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T: Ependymomas in children: histologic and DNA-flow cytometric study. Pediatr Pathology 14: 453-466, 1994

    Google Scholar 

  14. Ross GW, Rubinstein LJ: Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31-36, 1989

    PubMed  Google Scholar 

  15. Schiffer D, Chio A, Giordana MT, Migheli A, Palma L, Pollo B, Soffietti R, Tribolo A: Histologic prognostic factors in ependymomas. Childs Nerv Syst 7: 177-182, 1991

    PubMed  Google Scholar 

  16. Shuman RM, Alvord EC Jr, Leech RW: The biology of childhood ependymomas. Arch Neurol 32: 731-739, 1975

    PubMed  Google Scholar 

  17. Goldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ, Laehy JM, Rorke LB, Schut L, D'Angio GJ: Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66: 557-563, 1990

    PubMed  Google Scholar 

  18. Mørk SJ, Løken AC: Ependymoma. A follow-up study of 101 cases. Cancer 40: 907-915, 1977

    PubMed  Google Scholar 

  19. Chiu J, Woo S, Ater J, Connelly JM, Bruner JM, Maor MH, van Eys J, Oswald MJ, Shallenberger R: Intracranial ependymoma in children: analysis of prognostic factors. Neurooncology 13: 283-290, 1992

    Google Scholar 

  20. Ferrante L, Mastronardi L, Schettini G, Lunardi P, Fortuna A: Fourth ventricle ependymomas. Acta Neurochir (Wien) 131: 67-74, 1994

    Google Scholar 

  21. Lyons MK, Kelly PJ: Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 28: 659-665, 1991

    PubMed  Google Scholar 

  22. Vigliani M, Schiffer D: Prognosis and treatment of ‘anaplastic’ ependymoma. Critical Review of Neurosurgery 2: 34-43, 1992

    Google Scholar 

  23. Asai A, Hoshino T, Edwards M, Davis RL: Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8: 273-278, 1992

    PubMed  Google Scholar 

  24. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T: Proliferative potential of brain tumors. Analysis with Ki 67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling and nucleolar organizer region counts. Cancer 71: 199-206, 1993

    PubMed  Google Scholar 

  25. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors: a study of MIB-1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 87: 47-54, 1994

    Google Scholar 

  26. Nagashima T, Hoshino T, Cho KG, Edwards MS, Hudgins RJ, Davis RL: The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling. Cancer 61: 2433-2438, 1988

    PubMed  Google Scholar 

  27. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mchracin P, Stavrou D: Relationship between Ki-67 positive cells, growth rate, and histological type of human intracranial tumors. Anticancer Res 8: 537-544, 1988

    PubMed  Google Scholar 

  28. Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ: Disseminated ependymomas of the central nervous system. J Neurosurg 85: 618-624, 1996

    PubMed  Google Scholar 

  29. Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489-503, 1990

    PubMed  Google Scholar 

  30. Cattoretti G, Becker M, Key G, Duchrow M, Schluter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant part of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 356-363, 1992

    Google Scholar 

  31. Shi S, Keu ME, Kaira KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991

    PubMed  Google Scholar 

  32. Tomita T, McLone D, Das L, Brand WN: Benign ependymomas of the posterior fossa in childhood. Pediatr Neuroscience 14: 277, 1988

    Google Scholar 

  33. Salazar O, Castro-Vita H, VanHoutte P, Rubin P, Aygun C: Improved survival in cases of intracranial ependymoma after radiation therapy: late report and recommendations. J Neurosurg 59: 652-659, 1984

    Google Scholar 

  34. Ernestus RI, Wilcke O, Schröder R: Supratentorial ependymomas in childhood: clinicopathological findings and prognosis. Acta Neurochir (Wien) 111: 96-102, 1991

    Google Scholar 

  35. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984

    PubMed  Google Scholar 

  36. Gerdes J, Li L, Schleuter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867-873, 1991

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Medical College of Virginia, Richmond, VA

    Ann M. Ritter

  2. Department of Pathology (Neuropathology), The University of Texas M.D. Anderson Cancer Center, Houston, TX

    Lauren A. Langford

  3. Department of Biomathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX

    Kenneth R. Hess

  4. Department of Pathology, Duke University Medical Center, Durham, NC, USA

    Roger E. McLendon

Authors
  1. Ann M. Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth R. Hess
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger E. McLendon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lauren A. Langford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritter, A.M., Hess, K.R., McLendon, R.E. et al. Ependymomas: MIB-1 proliferation index and survival. J Neurooncol 40, 51–57 (1998). https://doi.org/10.1023/A:1006082622699

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006082622699

Search

Navigation